VSee Health Statistics
Total Valuation
VSee Health has a market cap or net worth of $11.43 million. The enterprise value is $20.65 million.
Important Dates
The next estimated earnings date is Friday, November 14, 2025, before market open.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VSee Health has 16.44 million shares outstanding. The number of shares has increased by 2.15% in one year.
| Current Share Class | 16.44M |
| Shares Outstanding | 16.44M |
| Shares Change (YoY) | +2.15% |
| Shares Change (QoQ) | +4.78% |
| Owned by Insiders (%) | 42.73% |
| Owned by Institutions (%) | 5.11% |
| Float | 6.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.68 |
| Forward PS | 0.92 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.16
| Current Ratio | 0.16 |
| Quick Ratio | 0.14 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -22.15 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -28.14% |
| Return on Invested Capital (ROIC) | -101.40% |
| Return on Capital Employed (ROCE) | -476.79% |
| Revenue Per Employee | $67,671 |
| Profits Per Employee | -$374,688 |
| Employee Count | 154 |
| Asset Turnover | 1.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.64M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.56% in the last 52 weeks. The beta is 0.35, so VSee Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | -56.56% |
| 50-Day Moving Average | 1.04 |
| 200-Day Moving Average | 1.27 |
| Relative Strength Index (RSI) | 36.57 |
| Average Volume (20 Days) | 81,588 |
Short Selling Information
The latest short interest is 90,108, so 0.55% of the outstanding shares have been sold short.
| Short Interest | 90,108 |
| Short Previous Month | 135,650 |
| Short % of Shares Out | 0.55% |
| Short % of Float | 1.38% |
| Short Ratio (days to cover) | 0.49 |
Income Statement
In the last 12 months, VSee Health had revenue of $10.42 million and -$57.70 million in losses. Loss per share was -$5.65.
| Revenue | 10.42M |
| Gross Profit | 7.18M |
| Operating Income | -4.68M |
| Pretax Income | -2.52M |
| Net Income | -57.70M |
| EBITDA | -3.36M |
| EBIT | -4.68M |
| Loss Per Share | -$5.65 |
Full Income StatementBalance Sheet
The company has $326,115 in cash and $9.55 million in debt, giving a net cash position of -$9.22 million or -$0.56 per share.
| Cash & Cash Equivalents | 326,115 |
| Total Debt | 9.55M |
| Net Cash | -9.22M |
| Net Cash Per Share | -$0.56 |
| Equity (Book Value) | -18,488 |
| Book Value Per Share | -0.00 |
| Working Capital | -15.99M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.79 million and capital expenditures -$55,267, giving a free cash flow of -$5.84 million.
| Operating Cash Flow | -5.79M |
| Capital Expenditures | -55,267 |
| Free Cash Flow | -5.84M |
| FCF Per Share | -$0.36 |
Full Cash Flow StatementMargins
| Gross Margin | 68.87% |
| Operating Margin | -44.94% |
| Pretax Margin | -569.46% |
| Profit Margin | n/a |
| EBITDA Margin | -32.24% |
| EBIT Margin | -44.94% |
| FCF Margin | n/a |
Dividends & Yields
VSee Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.15% |
| Shareholder Yield | -2.15% |
| Earnings Yield | -504.86% |
| FCF Yield | -51.14% |
Analyst Forecast
The average price target for VSee Health is $5.00, which is 619.32% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.00 |
| Price Target Difference | 619.32% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VSee Health has an Altman Z-Score of -3.73 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.73 |
| Piotroski F-Score | 3 |
